Zymedi
PrivateLast Round
Series A
Extension
May 30, 2023
Total Funding Raised
$28.85M
Company Overview
Zymedi is a biotechnology company that develops a novel therapeutics platform intended to improve the quality of life for people suffering from diseases by focusing on aminoacyl-tRNA synthetases (ARSs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zymedi Comps
Public and private peers based on sector, stage, and business model.
Zymedi Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | May 30, 2023 | ||||
| Series A | Mar 26, 2021 | ||||
| Angel | Oct 1, 2020 |
Key People
Founding team and executive leadership
Zymedi Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Company K Partners, Limited | Series A, Series A Extension |
| CKD Venture Capital | Series A Extension |
| UTC Investment | Series A, Series A Extension |
| Medytox Venture Investment | Series A Extension |
| Korea Development Bank | Series A Extension |
| Korea Venture Investment Corporation | Series A Extension |
| Atinum Investment | Series A, Series A Extension |
Zymedi Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Zymedi's valuation, stock price, and market status.
